(Q35691937)

9 August 2017

1 reference

title

Occult hepatitis B virus infection: implications in transfusion (English)

1 reference

9 August 2017

1 reference

1 reference

Allain JP

1

1 reference

9 August 2017

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

86

1 reference

9 August 2017

83-91

1 reference

9 August 2017

2

1 reference

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

9 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Occult hepatitis B virus infection and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Identification of different states of hepatitis B virus infection with a quantitative PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Hepatitis B virus markers in anti-HBc only positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Detection of hepatitis B virus DNA in blood units with anti-HBc as the only positive serological marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00406.X

10.1111/J.0042-9007.2004.00406.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15023176